Funding for this research was provided by:
Bayer Vital GmbH, Leverkusen, Germany
Received: 29 March 2018
Accepted: 31 July 2018
First Online: 24 August 2018
Ethics approval and consent to participate
: The Ethics Committee of the Medical Faculty of the University of Göttingen, Germany, approved the study (application number 12/8/12). All participants provided written informed consent to participate in the study.
: Not applicable.
: SK received study grants from Bayer Vital GmbH and BiogenIdec, personal compensation as a speaker from Bayer Vital GmbH, BiogenIdec, UCB, Pfizer, and Novartis. TN, MD and MS are full-time employees of Bayer Vital GmbH. MS previously served as an associate editor to BMC Neurology. PB is a full-time employee of Bayer Consumer Care AG. TG is a former employee of Bayer Vital GmbH and currently a consultant to Bayer Vital GmbH. CN is a full-time employee of Bayer AG.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.